FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986178002> ?p ?o ?g. }

• W1986178002 endingPage "9217" @default.
• W1986178002 startingPage "9207" @default.
• W1986178002 abstract "ABSTRACT Hepatitis C virus (HCV) sets up a persistent infection in patients that likely involves a complex virus-host interaction. We previously found that the HCV nonstructural 5A (NS5A) protein interacts with growth factor receptor-binding protein 2 (Grb2) adaptor protein and inhibits the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) by epidermal growth factor (EGF). In the present study, we extended this analysis and investigated the specificity of the Grb2-NS5A interaction and whether the subversion of mitogenic signaling involves additional pathways. NS5A containing mutations within the C-terminal proline-rich motif neither bound Grb2 nor inhibited ERK1/2 activation by EGF, demonstrating that NS5A-Grb2 binding and downstream effects were due to direct interactions. Interestingly, NS5A could also form a complex with the Grb2-associated binder 1 (Gab1) protein in an EGF treatment-dependent manner. However, the NS5A-Gab1 association, which appeared indirect, was not mediated by direct NS5A-Grb2 interaction but was likely dependent on direct NS5A interaction with the p85 subunit of phosphatidylinositol 3-kinase (PI3K). The in vivo association of NS5A with p85 PI3K required the N-terminal, but not the C-terminal, region of NS5A. The downstream effects of the NS5A-p85 PI3K interaction included increased tyrosine phosphorylation of p85 PI3K in response to EGF. Consistent with this observation and the antiapoptotic properties of NS5A, we also detected enhanced tyrosine phosphorylation of the downstream AKT protein kinase and increased serine phosphorylation of BAD, a proapoptotic factor and an AKT substrate, in the presence of NS5A. These results collectively suggest a model in which NS5A interacts with Grb2 to inhibit mitogenic signaling while simultaneously promoting the PI3K-AKT cell survival pathway by interaction with p85 PI3K, which may represent a crucial step in HCV persistence and pathogenesis." @default.
• W1986178002 created "2016-06-24" @default.
• W1986178002 creator A5003444463 @default.
• W1986178002 creator A5007657047 @default.
• W1986178002 creator A5018741681 @default.
• W1986178002 creator A5026474866 @default.
• W1986178002 creator A5033678604 @default.
• W1986178002 creator A5036980616 @default.
• W1986178002 creator A5038247833 @default.
• W1986178002 creator A5084834429 @default.
• W1986178002 date "2002-09-15" @default.
• W1986178002 modified "2023-10-11" @default.
• W1986178002 title "Subversion of Cell Signaling Pathways by Hepatitis C Virus Nonstructural 5A Protein via Interaction with Grb2 and P85 Phosphatidylinositol 3-Kinase" @default.
• W1986178002 cites W1576582350 @default.
• W1986178002 cites W1779251134 @default.
• W1986178002 cites W1791888878 @default.
• W1986178002 cites W1968426124 @default.
• W1986178002 cites W1971727526 @default.
• W1986178002 cites W1979012323 @default.
• W1986178002 cites W1993881377 @default.
• W1986178002 cites W1997307715 @default.
• W1986178002 cites W2006757932 @default.
• W1986178002 cites W2009354010 @default.
• W1986178002 cites W2012219375 @default.
• W1986178002 cites W2014165835 @default.
• W1986178002 cites W2016876202 @default.
• W1986178002 cites W2017292900 @default.
• W1986178002 cites W2024086482 @default.
• W1986178002 cites W2024682565 @default.
• W1986178002 cites W2027252289 @default.
• W1986178002 cites W2030955009 @default.
• W1986178002 cites W2034786275 @default.
• W1986178002 cites W2035312783 @default.
• W1986178002 cites W2043585116 @default.
• W1986178002 cites W2057809644 @default.
• W1986178002 cites W2059457521 @default.
• W1986178002 cites W2073675795 @default.
• W1986178002 cites W2077478539 @default.
• W1986178002 cites W2078887917 @default.
• W1986178002 cites W2079071516 @default.
• W1986178002 cites W2080520906 @default.
• W1986178002 cites W2092470099 @default.
• W1986178002 cites W2093813815 @default.
• W1986178002 cites W2095541301 @default.
• W1986178002 cites W2097767970 @default.
• W1986178002 cites W2098840577 @default.
• W1986178002 cites W2103413622 @default.
• W1986178002 cites W2104669000 @default.
• W1986178002 cites W2109092505 @default.
• W1986178002 cites W2116277533 @default.
• W1986178002 cites W2122151579 @default.
• W1986178002 cites W2135909641 @default.
• W1986178002 cites W2137242412 @default.
• W1986178002 cites W2137934927 @default.
• W1986178002 cites W2150418339 @default.
• W1986178002 cites W2151898297 @default.
• W1986178002 cites W2155731494 @default.
• W1986178002 cites W2158697492 @default.
• W1986178002 cites W2159147754 @default.
• W1986178002 cites W2159327683 @default.
• W1986178002 cites W2166086535 @default.
• W1986178002 cites W2189392311 @default.
• W1986178002 cites W2316574060 @default.
• W1986178002 cites W2335845212 @default.
• W1986178002 cites W2491492261 @default.
• W1986178002 cites W4236571285 @default.
• W1986178002 cites W4244540255 @default.
• W1986178002 cites W4361865146 @default.
• W1986178002 doi "https://doi.org/10.1128/jvi.76.18.9207-9217.2002" @default.
• W1986178002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/136456" @default.
• W1986178002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12186904" @default.
• W1986178002 hasPublicationYear "2002" @default.
• W1986178002 type Work @default.
• W1986178002 sameAs 1986178002 @default.
• W1986178002 citedByCount "160" @default.
• W1986178002 countsByYear W19861780022012 @default.
• W1986178002 countsByYear W19861780022013 @default.
• W1986178002 countsByYear W19861780022014 @default.
• W1986178002 countsByYear W19861780022015 @default.
• W1986178002 countsByYear W19861780022016 @default.
• W1986178002 countsByYear W19861780022017 @default.
• W1986178002 countsByYear W19861780022018 @default.
• W1986178002 countsByYear W19861780022019 @default.
• W1986178002 countsByYear W19861780022020 @default.
• W1986178002 countsByYear W19861780022021 @default.
• W1986178002 countsByYear W19861780022022 @default.
• W1986178002 countsByYear W19861780022023 @default.
• W1986178002 crossrefType "journal-article" @default.
• W1986178002 hasAuthorship W1986178002A5003444463 @default.
• W1986178002 hasAuthorship W1986178002A5007657047 @default.
• W1986178002 hasAuthorship W1986178002A5018741681 @default.
• W1986178002 hasAuthorship W1986178002A5026474866 @default.
• W1986178002 hasAuthorship W1986178002A5033678604 @default.
• W1986178002 hasAuthorship W1986178002A5036980616 @default.
• W1986178002 hasAuthorship W1986178002A5038247833 @default.
• W1986178002 hasAuthorship W1986178002A5084834429 @default.
• W1986178002 hasBestOaLocation W19861780022 @default.
• W1986178002 hasConcept C108636557 @default.

• next